CC BY
10Porphyrins Порфирины
Макрогэтэроцмклы
http://macroheterocycles.isuct.ru
Communication Сообщение
DOI: 10.6060/mhc161072g
Synthesis of Hydroxy Derivatives of Chlorin e6
Olga I. Gushchina,@ Milana Yu. Grishina, Ekaterina A. Larkina, Victoriya S. Lebedeva, and Andrey F. Mironov
Moscow Technological University (Institute of Fine Chemical Technologies), 119571 Moscow, Russia ®Corresponding author E-mail: [email protected]
There is a simple scheme of synthesis of new chlorin photosensitizers (PS) based on chlorin e6 hydroxy derivatives. For the disclosure of exocycle of the initial compounds - pheophorbide a and its methyl ester we used aliphatic aminoalco-hols with 2-6 carbon atoms in the alkyl chain. The reaction was carried out under mild conditions in chloroform/dichlo-romethane with heating up to 40 °C. The structure of all compounds obtained was confirmed by means of electronic, IR, 1H NMR spectroscopy and mass-spectrometry. The yields of compounds 2a-e and 3b-e were 60-75 %. It is necessary to note that chlorin e6 hydroxy derivatives 2a-e could be soluble in water using alkaline compounds as excipients (namely KOH, NaOH). This fact is important and valuable because many effective porphyrin and chlorin PS are insoluble in water systems and obtaining of chlorin e6 is time-consuming and hard work. Thus, in this paper we propose a reliable scheme of synthesis of new chlorin's photosensitizers which are promising agents for PDT.
Keywords: Chlorin e6, synthesis, hydroxy derivatives, photodynamic therapy (PDT).
Синтез гидроксипроизводных хлорина е6
О. И. Гущина,@ М. Ю. Гришина, Е. А. Ларкина, В. С. Лебедева, А. Ф. Миронов
Московский технологический университет (Институт тонких химических технологий), 119571 Москва, Россия @Е-таИ: [email protected]
Осуществлён синтез гидроксипроизводных хлорина е6 путём присоединения аминоспиртов к феофорбиду а и его метиловому эфиру. Гидроксиамидные производные хлорина е6 2а-е растворимы в щелочных водных растворах и являются перспективными агентами для ФДТ.
Ключевые слова: Хлорин е, синтез, гидроксипроизводные, фотодинамическая терапия (ФДТ).
Nowadays photodynamic therapy plays an important role in oncology diseases treatment.[1-3] Due to high efficiency, minimal contraindications, good patient acceptability and excellent cosmetic effect PDT finds an application for treatment of different types of tumors.[4-5] Unfortunately, there are some limits for photosensitizers used in medicine (namely selectivity, light depth penetration, stability etc.). Because of PDT's significance and actuality, development of new effective photosensitizers is an actual task at the moment.[6]
Pharmaceuticals based on chlorin e6 approve themself to be reliable photosensitizers.[4,7] But its synthesis is time-consuming. One of the possible ways for obtaining of chlorin's photosensitizers is opening of cyclopentanone fragment in pheophorbide a.[8-10] Following this idea
alkylamides,[11,12] aminoamides[13,14] and hydroxyamides[14,15] of chlorin e6 were synthesized.
Our investigations are based on synthesis of chlorin photosensitizers from methyl ester of pheophorbide a using amino alcohols. This type of reaction was earlier provided for 17(3)-methyl ester of pheophorbide a with 2-aminoethanol as nucleophilic agent.[14] We expanded the number of amino alcohols with 3-6 carbon atoms in the alkyl chain (Scheme 1) and succeeded in opening of cyclopentanone fragment in pheophorbide a. We used for our synthesis this sequence of amino alcohols to evaluate the dependence of physicochemical properties on length of the hydrocarbon chain. The reactions were carried out under mild conditions with good yields 60-75 %. During the experiment we
Макрогетероциклы /Macroheterocycles 2017 10(1) 81-83
© ISUCT Publishing
81
Synthesis of Hydroxy Derivatives of Chlorin e
R,OOC
Scheme 1.
1a R1=H 1b R1=CH3
R1OOC
COOCH,O
1a-e R1=H, n=2-6 1b-e R1=CH3, n=3-6
used a 30-fold excess of the amino alcohol relatively the pheophorbide a and its methyl ester (1a and 1b).
The reaction was monitored by TLC and electronic spectroscopy. We observed the hypsochromic shift of the Soret and Q absorption bands from 413 and 668 nm to 403 and 663 nm respectively in the electronic spectrum.
The compounds obtained were purified by column chromatography and characterized by IR, 'H NMR spectroscopy and mass spectrometry. To demonstrate the purification efficacy and accuracy of the results the 'H NMR spectrum fragment of 3d is shown in Figure 1.
It is interesting to note that the compounds 2a-e were soluble in water using alkaline substances as excipients. In the extraction process (washing after reaction complete) these substances remained in water layer. Using 3 % HCl solution allowed us to separate compounds 2a-e. After all steps of purification (including column chromatography) compounds 2a-e were soluble in alkaline water. Thus, these pho-tosensitizers 2a-e are readily synthesized chlorin e6 derivatives that could be transferred in water-soluble forms. Moreover, we can regard them as perspective agents for PDT.
Experimental
Electronic spectra were recorded on a spectrophotometer JASCO UV/VIS 7800 (Japan) in the range of 350-750 nm in
chloroform. Mass-spectra were recorded on a Ultraflex TOF/TOF using MALDI method and 2,5-dihydroxybenzoic acid as a matrix. 'H NMR spectra were recorded on a Bruker DPX-300 (Germany) in CDCl3 at 298 K. Chemical shifts were measured using signal at 7.26 ppm for residual protons of CHCl3 as a reference.
13(1)-N-(2-Hydroxyaminoethyl)amide-15(2)-methyl ester of chlorin e6 (2a). The 0.1 mL of aminoethanol (1.50 mmol) was added to the solution of 25.4 mg of pheophorbide a (0.043 mmol) 1a in chloroform (2 mL). The reaction mixture was stirred for 2 hours under an inert atmosphere by heating to 40 °C. The reaction mixture was poured into 3 % HCl solution, organic layer was separated, washed with water to pH=7, dried with Na 2SO4 and then concentrated to dryness. The residue was purified by silica gel (0.040-0.063 mm, Merck, Germany) column chromatography using chloroform/methanol (5:1 by volume) to get pure hydroxy derivative of chlorin e6. Yield 12 mg (43 %). UV-Vis (CHCl3) Xmax nm: 403.0; 502.3; 529.8; 663.2. 'H NMR (CDCl3) 5 ppm: 9.85 (s, 1H, 10-H); 9.78 (s, 1H, 5-H); 8.98 (s, 1H, 20-H); 8.07 (dd, 1H, J=17.8 Hz, J=11.5 Hz, 3(1)-H); 6.34 (dd, 1H, J=17.8 Hz, trans-3(2)-H); 6.21 (dd, 1H, J=11.5 Hz, cis-3(2)-H); 5.61 d. and 5.37 d. (1H each, J=19.03 Hz, 15(1)-H); 4.58-4.46 (m, 2H 17-H, 18-H); 4.04-3.71 (m, 4H, 13(3,4)-CH2-CH2-OH); 3.90 (s, 3H, 15(3)-CH3); 3.64-3.53 (m, 5H, 8(1)-CH2, 12(1)-CH3); 3.52-3.49 (s, 3H, 2(1)-CH3); 3.363.32 (m, 3H, 7(1)-CH3); 2.52-2.05 (m, 4H, 17(1)-H, 17(2)-H); 1.73 (d, 3H, 18(1)-H, J=6.9 Hz); 1.65 (t, 3H, 8(2)-CH3). Mass-spectrum, m/z: calculated for [C, H NOJ+ 653.321, found: 653.154.
l 37 43 6 5 j 3
13(1)-N-(2-Hydroxyaminopropyl)amide-15(2)-methyl ester of chlorin e6 (2b). Compound was obtained similarly to 2a. Yield 16 mg (47 %) from 30.3 mg of 1a. UV-Vis (CHCl3) Xmx nm: 403.6; 502.'; 527.8; 663.3. 'H NMR (CDCl3) 5 ppm: 9.74 (s, 1H, 10-H); 9.68 (s, 1H, 5-H); 8.89 (s, 1H, 20-H); 8.04 (dd, 1H, J=17.8 Hz, J=11.5 Hz, 3(1)-H); 6.33 (dd, 1H, J=17.82 Hz, trans-3(2)-H); 6.16 (dd, 1H, J=11.5 Hz, cis-3(2)-H); 5.52 d. and 5.29 d. (1H each, J=18.86 Hz, 15(1)-H); 4.49 (m, 1H, 18-H); 4.41 (m, 1H, 17-H); 3.83-3.7 (m, 4H, 13(2)-CH2, 13(4)-CH2-OH); 3.80 (s, 3H, 15(3)-CH3); 3.61-3.50 (m, 5H, 8(1)-CH2, 12(1)-CH3); 3.48 (s, 3H, 2(1)-CH3); 3.30 (s, 3H, 7(1)-CH3); 2.6-1.9 (m, 4H, 17(1)-H, 17(2)-H); 1.775-1.62 (m, 8H, 18(1)-CH3, 8(2)-CH3, 13(3)-CH2). Mass-spectrum, m/z: calculated for [C38H45N6O5]+ 667.337, found: 667.3'0.
13(1)-N-(2-Hydroxyaminobutyl)amide-15(2)-methyl ester of chlorin e6 (2c). Compound was obtained similarly to 2a. Yield 19 mg (53.5 %) from 31 mg of 1a. UV-Vis (CHCl3) nm: 404.2; 500.9; 53'.2; 663.0. 'H NMR (CDCl3) 5 ppm: 10.06 (m,"m, 10-H); 9.99 (s, 1H, 5-H); 9.17 (s, 1H, 20-H); 8.09 (dd, 1H, J=17.8 Hz, J=11.5 Hz, 3(1)-H); 6.38 (dd, 1H, J=17.8 Hz, trans-3(2)-H); 6.32 (dd, 1H, J=11.5 Hz, cis-3(2)-H); 5.89 d. and 5.39 d. (1H each, J=19.87 Hz, 15(1)-H); 4.67-4.54 (m, 2H, 18-H, 17-H); 3.97-3.75 (m, 4H, 13(2)-
9.76 9.71 Oi
CO 8.13 -8.09 .Q HT U.UI -8.03 a c c § CsJ 00 m T co <0 to ^ V •5.60 0 O Oi ri ^ CO IT. CM { ih c ■4.39
Jn| CD i' 1 n-1 SI t i i.
T T T- V >7
1.11 1.02 0 0 LO O 0.91 2.14 O) O) 0 00 0 Is-CN
T---1->-1-1-1---1-'-1-1-1---1-1-1-1-1---r-1-r
10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5
f1
Figure 1. Fragment of 'H NMR spectrum of 3d.
82
Макрогeтeр0циmbl /Macroheterocycles 2017 10(') 8'-83
O. I. Gushchina et al.
CH2, 13(5)-CH2-OH); 3.83 (s, 3H, 15(3)-CH3); 3.66-3.57 (m, 5H, 8(1)-CH2, 12(1)-CH3); 3.42 (s, 3H, 2(1)-CH3); 3.35 (s, 3H, 7(1)-CH3); 2.(5-2.3 (m, 4H, 17(1)-H, 17(2)-H); 1.82-1.57 (m, 10H, 18(1)-H, J=7.31Hz, 8(2)-CH3, 13(3,4)-CH2-CH2). Mass-spectrum, m/z: calculated for [C H, ,N0,1+ 681.353, found: 681.815.
L 39 47 6 5J 3
13(1)-N-(2-Hydroxyaminopentyl)amide-15(2)-methyl ester of chlorin e6 (2d). Compound was obtained similarly to 2a. Yield 24.8 mg (70.5 %) from 30.06 mg of 1a. UV-Vis (CHCl3) Xmax nm: 403.4; 502.3; 663.2. 'H NMR (CDCl3) 5 ppm: 9.73 (s, 1H, llO-H); 9.69 (s, 1H, 5-H); 8.88 (s, 1H, 20-H); 8.05 (dd, 1H, J=17.8 Hz, J=11.5 Hz, 3(1)-H); 6.33 (dd, 1H, J=17.8 Hz, trans-3(2)-H); 6.15 (dd, 1H, J=11.5 Hz, cis-3(2)-H); 5.53 d. and 5.31 d. (1H each, J=18.46 Hz, 15(1)-H); 4.49 (m, 1H, 18-H); 4.40 (m, 1H, 17-H); 3.86-3.7 (m, 4H, 13(2)-CH2, 13(6)-CH2-OH); 3.76 (s, 3H, 15(3)-CH3); 3.58-3.50 (m, 5H, 8(1)-CH2, 12(1)-CH3 ); 3.48 (s, 3H, 2(1)-CH3); 3.31 (s, 3H, 7(1)-CH3); 2.11-2.61 (m, 4H, 17(1)-H, 17(2)-H); 2.0-1.68 (m, 9H, 18(1)-CH3, J=7.37 Hz, 13(3,4,5)-CH2-CH2-CH2); 0.85 (t, 3H, 12(2)-CH3).
13(1)-N-(2-Hydroxyaminohexyl)amide-15(2)-methyl ester of chlorin e6 (2e). Compound was obtained similarly to 2a. Yield 15 mg (50.5 %) from 24.9 mg of 1a. UV-Vis (CHCl3) Xmax nm: 403.9; 503.0; 532.8; 663.0. 'H NMR (CDCl3) 5 ppm: 9.78 (s,mffl, 10-H); 9.74 (s, 1H, 5-H); 8.93 (s, 1H, 20-H); 8.06 (dd, 1H, J=17.8 Hz, J=11.5 Hz, 3(1)-H); 6.34 (dd, 1H, J=17.8 Hz, trans-3(2)-H); 6.18 (dd, 1H, J=11.5 Hz, cis-3(2)-H); 5.56 d. and 5.32 d. (1H each, J=18.49 Hz, 15(1)-H); 4.55-4.39 (m, 2H, 18-H, 17-H); 3.83-3.74 (m, 4H, 13(2)-CH2, 13(7)-CH2-OH); 3.80 (s, 3H, 15(3)-CH3); 3.56-3.51 (m, 5H, 8(1;»-^, 12(1>CH3 ); 3.49 (s, 3H, 2(1)-CH3); 3.32 (s, 3H, 7(1)-CH3); 2.7-1.99 (m, 4H, 17(1)-H, 17(2)-H); 1.90-1.4 (m 17H, 18(1)-CH3, 13(3,4,5,6)-CH2-CH2-CH2-CH2, 8(2)-CH3 8(2)-CH3). Massspectrum, m/z: calculated for [C41H51N605]+ 709.3384, found: 709.944.
13(1) -N-(2-Hydroxyaminopropyl)amide-15(2),17(3)-dimethyl ester of chlorin e6 (3b). The 0.12 mL 3-aminopropanol (1.47 mmol) was added to the solution of 29.9 mg of 17(3)-methyl ester of pheophorbide a (0.049 mmol) 1b in chloroform (2 mL). The reaction mixture was stirred for 2 hours under an inert atmosphere at heating to 40 °C. The reaction mixture was washed with water to pH=7, organic layer was separated, dried with Na2S04 and then concentrated to dryness. The residue was purified by silica gel (0.040-0.063 mm, Merck, Germany) column chromatography using chloroform/methanol (10:1 by volume) to get pure hydroxy derivative of chlorin e6 Yield 19.8 mg (59 %). UV-Vis (CHCl3) Xmax nm: 403.5; 500.8; 663.4. 'H NMR (CDCl3) 5 ppm: 9.73 (s, 1H, 10-H); 9.68 (s, 1H, 5-H); 8.92 (s, 1H, 20-H); 8 (dd, 1H, J=17.8 Hz, J=11.5 Hz, 3(1)-CH);7.2 (br. t, 1H, 13(1)-NH; 6.33 (dd, 1H, J=17.8 Hz, trans-3(2)-CH2); 6.16 (dd, 1H, J=11.5 Hz, cis-3(2)-CH2); 5.48 d. and 5.19 d. (1H each, J=18.85 Hz, 15(1)-CH2); 4.51 (m, 1H, 18-H); 4.39 (m, 1H, 17-H); 3.85-3.75 (m, 4H, 13(2 )-CH2, 13(4)-CH2-OH); 3.81 (s, 3H, 15(3)-CH3); 3.63 (s, 3H, 12(1)-CH3);
3.50 (s, 3H, 2(1)-CH3); 3.29 (s, 3H, 7(1)-CH3); 2.12-2.62 (m, 4H, 17(1)-CH2, 17(2)-CH2); 1.83-1.75 (m, 5H, 18 (1)-CH3, J=7,37 Hz, 13(4)-CH2); 1.67 (t, 3H, 8(2)-CH3); -1.94 (br. s, 2H, 21-NH and 23-NH). Mass-spectrum, m/z: calculated for [C39H47N605]+ 681.353, found: 681.348.
13(1)-N-(2-Hydroxyaminobutyl)amide-15(2),17(3)-dimethyl ester of chlorin e6 (3c). Compound was obtained similarly to 3b. Yield 19.7 mg (57.2 %) from 30.03 mg of 1b. UV-Vis (CHCl3) Xmax nm: 402.9; 502.6; 530.8; 663.2. 1H NMR (CDCl3) 5 ppm: 9.73 (s, 1H, 10-H); 9.67 (s, 1H, 5-H); 8.88 (s, 1H, 20-H); 8.05 (dd, 1H, J=17.8 Hz, J=11.5 Hz, 3(1)-CH); 6.74 (br. t, 1H, 13(1)-NH; 6.33 (dd, 1H, J=17.8 Hz, trans-3(2)-CH2); 6.13 (dd, 1H, J=11.5 Hz, cis-3(2)-CH2); 5.53 d. and 5.23 d. (1H each, J=18.65 Hz, 15(1)-CH2);
4.51 (m, 1H, 18-H); 4.39 (m, 1H, 17-H); 3.88-3.73 (m, 4H, 13(2)-CH2, 13(5)-CH2-OH); 3.85 (s, 3H, 15(3)-CH3); 3.68-3.61 (m, 5H, 17(3)-CH3, 8(1)-CH2); 3.51 (s, 3H, 12(1)-CH3); 3.49 (s, 3H, 2(1)-CH3); 3.33 (s, 3H, 7(1)-CH3); 2.12-2.60 (m, 4H, 17(1)-CH2, 17(2)-CH2); 1.82-1.62 (m, 11H, 18(1)-CH3, 13(3,4)-CH2-CH2, 8(2)-CH3); -1.88 (br. s, 2H, 21-NH and 23-NH).
13(1)-N-(2-Hydroxyaminopentyl)amide-15(2),17(3)-dimethyl ester of chlorin e6 (3d). Compound was obtained similarly to 3b. Yield 25.4 mg (72.3 %) from 30.03 mg of 1b. UV-Vis (CHCl3) Xmax nm: 403.3; 500.7; 528.5; 663.0. 1H NMR (CDCl3) 5 ppm: 9.76 (s™1H, 10-H); 9.71 (s, 1H, 5-H); 8.89 (s, 1H, 20-H); 8.08 (dd, 1H, J=17.8 Hz, J=11.5 Hz, 3(1)-CH); 6.6 (br. t, 1H, 13(1)-NH; 6.35 (dd, 1H, J=17.8 Hz, trans-3(2)-CH2);6.16 (dd, 1H, J=11.5 Hz, cis-3(2)-CH2); 5.55 d. and 5.26 d. (1H each, J=18,84 Hz, 15(1)-CH2); 4.50 (m, 1H, 18-H); 3.94 (s, 3H, 15(3)-CH3); 4.39 (m, 1H, 17-H); 3.913.72 (m, 4H, 13(2)-CH2, 13(6)-CH2-OH); 3.69-3.6 (m, 5H, 17(3)-CH3, 8(1)-CH2; 3.55 (s, 3H, 12(1)-CH3); 3.50 (s, 3H, 2(1)-CH3); 3.33 (s, 3H, 7(1)-CH3); 2.11-2.63 (m, 4H, 17(1)-CH2, 17(2)-CH2); 1.8-1.43 (m, 11H, 18(1)-CH3, 13(3, 4, 5)-CH2-CH2-CH2, 8(2)-CH3); -1.87 (br. s, 2H, 21-NH and 23-NH).
13(1)-N-(2-Hydroxyaminohexyl)amide-15(2),17(3)-dimethyl ester of chlorin e6 (3e). Compound was obtained similar to 3b. Yield 16.7 mg (69.7 %) from 20.08 mg of 1b. UV-Vis (CHCl3) Xmax nm: 403.2; 502.7; 663.2. 1H NMR (CDCl3) 5 ppm: 9.78 (s, 1H, 10-H); 9.72 (s, 1H, 5-H); 8.89 (s, 1H, 20-H); 8.09 (dd, 1H, J=17.8 Hz, J=11.5 Hz, 3(1)-CH); 6.56 (br. t, 1H, 13(1)-NH; 6.37 (dd, 1H, J=17.8 Hz, trans-3(2)-CH2); 6.18 (dd, 1H, J=11.5 Hz, cis-3(2)-CH2); 5.58 d. and 5.27 d. (1H each, J=18.85 Hz, 15(1)-CH2); 4.51 (m, 1H, 18-H); 4.39 (m, 1H, 17-H); 3.95-3.72 (m, 4H, 13(2)-CH2, 13(7)-CH2-OH); 3.81 (s, 3H, 15(3)-CH3); 3.70-3.6 (m, 5H, 17(3)-CH3, 8(1)-CH2); 3.63 (s, 3H, 12(1)-CH3); 3.57 (s, 3H, 2(1)-CH3); 3.35 (s, 3H, 7(1)-CH3); 2.0-2.7 (m, 4H, 17(1)-CH2, 17(2)-CH2); 1.89-1.41 (m. 14H, 18(1)-CH3, 13(3,4,5,6)-CH2-CH2-CH2-CH2, 8(2)-CH3); -1.87 (br. s, 2H, 21-NH and 23-NH). Mass-spectrum, m/z: calculated for [C ,H N 0]+ 723.399, found: 723.892.
42 53 6 5
Acknowledgements. The work was financially supported by the RSF project №16-33-10092.
References
1. Bacellar I.O.L., Tsubone T.M., Pavani C., Baptista M.S. Int. J. Mol. Sci. 2015, 16, 20523-20559.
2. Grin M.A., Mironov A.F., Shtil A.A. Anti-Cancer Agents in Medicinal Chemistry 2008, 8, 683-697.
3. Agostinis P., Berg K., Cengel K.A., Foster T.H., Golab J. et al. CA Cancer J. Clin. 2011, 61, 250-281.
4. Ethirajan M., Chen Y.H., Joshi P., Pandey R.K. Chem. Soc. Rev. 2011, 40, 340-362.
5. Brown S.B., Brown E.A., Walker I.J. Lancet Oncol. 2004, 5, 497-508.
6. Voon S.H., Kiew L.V., Lee H.B., Lim S.H., Noordin M.I., Chung L.Y. et al. Small 2014, 10, 4993-5013.
7. Allison R.R., Sibata C.H. Photodiagnosis and Photodynamic Therapy 2010, 7, 61-75.
8. Belykh D.V., Kopylov E.A., Gruzdev I.V., Kuchin A.V. Russ. J. Org. Chem. 2010, 46, 577-585.
9. Kuchin A.V., Ol'shevskaya V.A., Mal'shakova M.V., Belykh D.V., Petrovskii P.V., Ivanov O.G., Shtil' A.A., Kalinin V.N. Doklady Akademii Nauk 2006, 409, 493-496.
10. Dugin N.O., Zavialova M.G., Novikov R.A., Timofeev VP., Mis-harinA.Yu., Ponomarev G.V Macroheterocycles 2012, 5, 146-148.
11. Gushchina O.I., Larkina E.A., Nikolskaya T.A., Mironov A.F. Photochem. Photobiol. B 2015, 153, 76-81.
12. Larkina E.A., Bui T.L. An', Tkachevskaya E.P., Mironov A.F. Vestnik MITHT 2008, 3, 106-108.
13. Belykh D.V., Malysheva M.V., Kuchin A.V. Patent RU 2304583, 2007.
14. Belykh D.V., Karmanova L.P., Spirikhin L.V., Kuchin A.V. Russ. J. Org. Chem. 2007, 43, 120-128.
15. Tarabukina I.S., Startseva O.M., Patov S.A., Belykh D.V. Macroheterocycles 2015, 8, 168-176.
Received 25.10.2016 Revised 11.01.2017 Accepted 14.01.2017
Макрогетероциклы /Macroheterocycles 2017 10(1) 81-83
83
